Trial record 2 of 2 for:
CLNP023A2301
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients (APPLAUSE-IgAN)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04578834 |
Recruitment Status :
Active, not recruiting
First Posted : October 8, 2020
Last Update Posted : May 3, 2024
|
Sponsor:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Estimated Primary Completion Date : | October 15, 2025 |
Estimated Study Completion Date : | October 15, 2025 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):